Genentech
FDA Approved Drugs

Genentech

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified RX
  • Total Records 37
  • Latest Approval Date Jan 30, 2012
  • Data Source FDA
  • First Approval Date Jan 30, 2012
All
37
View
Unclassified
36
View
RX
1
View
Company Overview

Company

Genentech

Country

U.S.A

Website

Visit Website

Email

leck@gene.com

Social Profiles

Company Snapshot

Genentech

1 DNA Way, South San Francisco, CA 94080

U.S.A

www.gene.com/ leck@gene.com View on Map
FDA Approved Drug Records ( 37 records )
-
Unclassified Application: 125276

Drug Name

ACTEMRA

Product Number

1

Dosage Form

-

Strength

80MG/4ML

Approval Date

-

125276 / 1

Active Ingredient

TOCILIZUMAB

Application Number

125276

Product Number

1

Dosage Form

-

Strength

80MG/4ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125276

Drug Name

ACTEMRA

Product Number

2

Dosage Form

-

Strength

200MG/10ML

Approval Date

-

125276 / 2

Active Ingredient

TOCILIZUMAB

Application Number

125276

Product Number

2

Dosage Form

-

Strength

200MG/10ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125276

Drug Name

ACTEMRA

Product Number

3

Dosage Form

-

Strength

400MG/20ML

Approval Date

-

125276 / 3

Active Ingredient

TOCILIZUMAB

Application Number

125276

Product Number

3

Dosage Form

-

Strength

400MG/20ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125472

Drug Name

ACTEMRA

Product Number

1

Dosage Form

-

Strength

162MG/0.9ML

Approval Date

-

125472 / 1

Active Ingredient

TOCILIZUMAB

Application Number

125472

Product Number

1

Dosage Form

-

Strength

162MG/0.9ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103172

Drug Name

ACTIVASE

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

-

103172 / 1

Active Ingredient

ALTEPLASE

Application Number

103172

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103172

Drug Name

ACTIVASE

Product Number

2

Dosage Form

-

Strength

50MG/VIAL

Approval Date

-

103172 / 2

Active Ingredient

ALTEPLASE

Application Number

103172

Product Number

2

Dosage Form

-

Strength

50MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125085

Drug Name

AVASTIN

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

125085 / 1

Active Ingredient

BEVACIZUMAB

Application Number

125085

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125085

Drug Name

AVASTIN

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

-

125085 / 2

Active Ingredient

BEVACIZUMAB

Application Number

125085

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103172

Drug Name

CATHFLO ACTIVASE

Product Number

3

Dosage Form

-

Strength

2MG/VIAL

Approval Date

-

103172 / 3

Active Ingredient

ALTEPLASE

Application Number

103172

Product Number

3

Dosage Form

-

Strength

2MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761149

Drug Name

ENSPRYNG

Product Number

1

Dosage Form

-

Strength

120MG/ML

Approval Date

-

761149 / 1

Active Ingredient

SATRALIZUMAB

Application Number

761149

Product Number

1

Dosage Form

-

Strength

120MG/ML

Approval Date

-

Regulatory Status

Unclassified

2012
30 Jan
RX Application: 203388

Drug Name

ERIVEDGE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2012-01-30

203388 / 1

Active Ingredient

VISMODEGIB

Application Number

203388

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2012-01-30

Regulatory Status

RX

-
Unclassified Application: 125486

Drug Name

GAZYVA

Product Number

1

Dosage Form

-

Strength

1000MG/40ML

Approval Date

-

125486 / 1

Active Ingredient

OBINUTUZUMAB

Application Number

125486

Product Number

1

Dosage Form

-

Strength

1000MG/40ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103792

Drug Name

HERCEPTIN

Product Number

1

Dosage Form

-

Strength

21MG/ML

Approval Date

-

103792 / 1

Active Ingredient

TRASTUZUMAB

Application Number

103792

Product Number

1

Dosage Form

-

Strength

21MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125427

Drug Name

KADCYLA

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

125427 / 1

Active Ingredient

ADO-TRASTUZUMAB EMTANSINE

Application Number

125427

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125427

Drug Name

KADCYLA

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

-

125427 / 2

Active Ingredient

ADO-TRASTUZUMAB EMTANSINE

Application Number

125427

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125156

Drug Name

LUCENTIS

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

-

125156 / 1

Active Ingredient

RANIBIZUMAB

Application Number

125156

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125156

Drug Name

LUCENTIS

Product Number

2

Dosage Form

-

Strength

6MG/ML

Approval Date

-

125156 / 2

Active Ingredient

RANIBIZUMAB

Application Number

125156

Product Number

2

Dosage Form

-

Strength

6MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19676

Drug Name

NUTROPIN

Product Number

1

Dosage Form

-

Strength

N/A

Approval Date

-

19676 / 1

Active Ingredient

SOMATROPIN [rDNA origin]

Application Number

19676

Product Number

1

Dosage Form

-

Strength

N/A

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20168

Drug Name

NUTROPIN

Product Number

1

Dosage Form

-

Strength

5MG/VIAL

Approval Date

-

20168 / 1

Active Ingredient

SOMATROPIN

Application Number

20168

Product Number

1

Dosage Form

-

Strength

5MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20168

Drug Name

NUTROPIN

Product Number

2

Dosage Form

-

Strength

10MG/VIAL

Approval Date

-

20168 / 2

Active Ingredient

SOMATROPIN

Application Number

20168

Product Number

2

Dosage Form

-

Strength

10MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20522

Drug Name

NUTROPIN AQ

Product Number

1

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

-

20522 / 1

Active Ingredient

SOMATROPIN

Application Number

20522

Product Number

1

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20522

Drug Name

NUTROPIN AQ NUSPIN

Product Number

3

Dosage Form

-

Strength

5MG/2ML (2.5MG/ML)

Approval Date

-

20522 / 3

Active Ingredient

SOMATROPIN

Application Number

20522

Product Number

3

Dosage Form

-

Strength

5MG/2ML (2.5MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20522

Drug Name

NUTROPIN AQ NUSPIN

Product Number

4

Dosage Form

-

Strength

20MG/2ML (10MG/ML)

Approval Date

-

20522 / 4

Active Ingredient

SOMATROPIN

Application Number

20522

Product Number

4

Dosage Form

-

Strength

20MG/2ML (10MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20522

Drug Name

NUTROPIN AQ NUSPIN

Product Number

5

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

-

20522 / 5

Active Ingredient

SOMATROPIN

Application Number

20522

Product Number

5

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20522

Drug Name

NUTROPIN AQ PEN

Product Number

2

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

-

20522 / 2

Active Ingredient

SOMATROPIN

Application Number

20522

Product Number

2

Dosage Form

-

Strength

10MG/2ML (5MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20522

Drug Name

NUTROPIN AQ PEN

Product Number

6

Dosage Form

-

Strength

20MG/2ML (10MG/ML)

Approval Date

-

20522 / 6

Active Ingredient

SOMATROPIN

Application Number

20522

Product Number

6

Dosage Form

-

Strength

20MG/2ML (10MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125409

Drug Name

PERJETA

Product Number

1

Dosage Form

-

Strength

420MG/14ML

Approval Date

-

125409 / 1

Active Ingredient

PERTUZUMAB

Application Number

125409

Product Number

1

Dosage Form

-

Strength

420MG/14ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761121

Drug Name

POLIVY

Product Number

1

Dosage Form

-

Strength

140MG/VIAL

Approval Date

-

761121 / 1

Active Ingredient

POLATUZUMAB VEDOTIN-PIIQ

Application Number

761121

Product Number

1

Dosage Form

-

Strength

140MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761121

Drug Name

POLIVY

Product Number

2

Dosage Form

-

Strength

30MG/VIAL

Approval Date

-

761121 / 2

Active Ingredient

POLATUZUMAB VEDOTIN-PIIQ

Application Number

761121

Product Number

2

Dosage Form

-

Strength

30MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103532

Drug Name

PULMOZYME

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

-

103532 / 1

Active Ingredient

DORNASE ALFA

Application Number

103532

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103705

Drug Name

RITUXAN

Product Number

1

Dosage Form

-

Strength

100MG/10ML (10MG/ML)

Approval Date

-

103705 / 1

Active Ingredient

RITUXIMAB

Application Number

103705

Product Number

1

Dosage Form

-

Strength

100MG/10ML (10MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103705

Drug Name

RITUXAN

Product Number

2

Dosage Form

-

Strength

500MG/50ML (10MG/ML)

Approval Date

-

103705 / 2

Active Ingredient

RITUXIMAB

Application Number

103705

Product Number

2

Dosage Form

-

Strength

500MG/50ML (10MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103909

Drug Name

TNKASE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

-

103909 / 1

Active Ingredient

TENECTEPLASE

Application Number

103909

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103976

Drug Name

XOLAIR

Product Number

1

Dosage Form

-

Strength

150MG/VIAL

Approval Date

-

103976 / 1

Active Ingredient

OMALIZUMAB

Application Number

103976

Product Number

1

Dosage Form

-

Strength

150MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103976

Drug Name

XOLAIR

Product Number

2

Dosage Form

-

Strength

75MG/0.5ML

Approval Date

-

103976 / 2

Active Ingredient

OMALIZUMAB

Application Number

103976

Product Number

2

Dosage Form

-

Strength

75MG/0.5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103976

Drug Name

XOLAIR

Product Number

3

Dosage Form

-

Strength

150MG/ML

Approval Date

-

103976 / 3

Active Ingredient

OMALIZUMAB

Application Number

103976

Product Number

3

Dosage Form

-

Strength

150MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 103976

Drug Name

XOLAIR

Product Number

4

Dosage Form

-

Strength

300MG/2ML

Approval Date

-

103976 / 4

Active Ingredient

OMALIZUMAB

Application Number

103976

Product Number

4

Dosage Form

-

Strength

300MG/2ML

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    37 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
37 total
  • Unclassified
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACTEMRA

Application Number

125276

Product Number

1

Active Ingredient

TOCILIZUMAB

Dosage Form

-

Strength

80MG/4ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit